Back to Results
First PageMeta Content
Pharmacology / Laboratories / Evidence-based medicine / Personalized medicine / Myriad Genetics / Medical laboratory / Medical research / Fluorouracil / Medicine / Health / Biology


Saladax Biomedical Laboratories to Offer the Full Portfolio of MyCare™ Therapeutic Dose Management Assays in the United States Saladax Regains Rights to the My5-FU™ Assay Licensed to and Marketed by Myriad Genetics a
Add to Reading List

Document Date: 2013-11-14 10:05:37

Open Document

File Size: 84,73 KB

Share Result on Facebook

City

Bethlehem / /

Company

Saladax Biomedical Inc. / Saladax Biomedical Laboratories / Myriad Genetics Inc. / /

Country

United States / /

Facility

CLIA laboratory / /

IndustryTerm

oncology dose management testing services / biotechnology / /

MedicalCondition

cancer / /

MedicalTreatment

chemotherapy / /

Person

Adrienne Choma / Mark D. Myslinski / Kevin Harter / /

Position

physician / CEO & President / VP and Chief Commercial Officer / /

Product

fluorouracil / /

ProvinceOrState

Pennsylvania / /

Technology

drug development / biotechnology / chemotherapy / /

SocialTag